Cite
Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.
MLA
Bea, Ana M., et al. “Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.” Clinical Chemistry, vol. 69, no. 2, Feb. 2023, pp. 140–48. EBSCOhost, https://doi.org/10.1093/clinchem/hvac213.
APA
Bea, A. M., Cenarro, A., Marco-Bened, V., Laclaustra, M., Martn, C., Ibarretxe, D., Pint, X., Arrobas, T., Vials, C., Civeira, F., & Olmos, S. (2023). Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype. Clinical Chemistry, 69(2), 140–148. https://doi.org/10.1093/clinchem/hvac213
Chicago
Bea, Ana M, Ana Cenarro, Victoria Marco-Bened, Martn Laclaustra, Csar Martn, Daiana Ibarretxe, Xavier Pint, et al. 2023. “Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.” Clinical Chemistry 69 (2): 140–48. doi:10.1093/clinchem/hvac213.